Get started
ARROWHEAD PHARMACEUTICALS INCARROWHEAD PHARMACEUTICALS INCARROWHEAD PHARMACEUTICALS INC

ARROWHEAD PHARMACEUTICALS INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ARWR chart


Full chart

ARWR upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪49.30 B‬ MXN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−98.51 MXN
Net income (FY)
‪−11.81 B‬ MXN
Revenue (FY)
‪69.97 M‬ MXN
Shares float
‪116.17 M‬
Beta (1Y)
1.80

Employees


Employees (FY)
609
Change (1Y)
+84 +16.00%
Revenue / Employee (1Y)
‪114.89 K‬ MXN
Net income / Employee (1Y)
‪−19.40 M‬ MXN

About Arrowhead Pharmaceuticals, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Christopher Richard Anzalone
Website
arrowheadpharma.com
Headquarters
Pasadena
Founded
1989
FIGI
BBG00TSG2G48
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ARWR news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of ARWR is 454.55 MXN — it has decreased by −18.83% in the past 24 hours. Watch ARROWHEAD PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange ARROWHEAD PHARMACEUTICALS INC stocks are traded under the ticker ARWR.
We've gathered analysts' opinions on ARROWHEAD PHARMACEUTICALS INC future price: according to them, ARWR price has a max estimate of 1,630.99 MXN and a min estimate of 489.30 MXN. Watch ARWR chart and read a more detailed ARROWHEAD PHARMACEUTICALS INC stock forecast: see what analysts think of ARROWHEAD PHARMACEUTICALS INC and suggest that you do with its stocks.
ARWR reached its all-time high on May 18, 2021 with the price of 1,850.00 MXN, and its all-time low was 454.55 MXN and was reached on Dec 5, 2024. View more price dynamics on ARWR chart.
See other stocks reaching their highest and lowest prices.
ARWR stock is 23.20% volatile and has beta coefficient of 1.80. Track ARROWHEAD PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is ARROWHEAD PHARMACEUTICALS INC there?
Today ARROWHEAD PHARMACEUTICALS INC has the market capitalization of ‪49.30 B‬, it has decreased by −12.18% over the last week.
Yes, you can track ARROWHEAD PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
ARROWHEAD PHARMACEUTICALS INC is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
ARWR earnings for the last quarter are −26.80 MXN per share, whereas the estimation was −22.08 MXN resulting in a −21.38% surprise. The estimated earnings for the next quarter are −8.18 MXN per share. See more details about ARROWHEAD PHARMACEUTICALS INC earnings.
ARROWHEAD PHARMACEUTICALS INC revenue for the last quarter amounts to 0.00 MXN, despite the estimated figure of ‪1.09 B‬ MXN. In the next quarter, revenue is expected to reach ‪1.47 B‬ MXN.
ARWR net income for the last quarter is ‪−3.36 B‬ MXN, while the quarter before that showed ‪−3.13 B‬ MXN of net income which accounts for −7.26% change. Track more ARROWHEAD PHARMACEUTICALS INC financial stats to get the full picture.
No, ARWR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 609.00 employees. See our rating of the largest employees — is ARROWHEAD PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ARROWHEAD PHARMACEUTICALS INC EBITDA is ‪−11.48 B‬ MXN, and current EBITDA margin is ‪−16.40 K‬%. See more stats in ARROWHEAD PHARMACEUTICALS INC financial statements.
Like other stocks, ARWR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ARROWHEAD PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ARROWHEAD PHARMACEUTICALS INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ARROWHEAD PHARMACEUTICALS INC stock shows the sell signal. See more of ARROWHEAD PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.